Back
Beam Therapeutics Stock Price Chart
Sponsored
BEAM
Sponsored
Free Stock Analysis Report: Get a clear concise Stock Rating
Analyze Any Stock Free
Sell
47
BEAM
Beam Therapeutics
Last Price:
$26.38
Seasonality Move:
-20.08%
7 Day Trial
ALL ACCESS PASS
$
7
Unlock the power of "two-minute trades"
Learn how today!-
The current trend is relatively stagnant and BEAM is experiencing slight buying pressure.
Beam Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.85 | Buy |
20-day SMA: | 27.22 | Sell |
50-day SMA: | 26.35 | Buy |
200-day SMA: | 25.5 | Buy |
8-day EMA: | 26.45 | Sell |
20-day EMA: | 26.72 | Sell |
50-day EMA: | 26.38 | Buy |
200-day EMA: | 26.33 | Buy |
Beam Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 48.59 | Sell |
Chaikin Money Flow: | 155671 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (25.71 - 28.69) | Sell |
Bollinger Bands (100): | (23.5 - 27.4) | Buy |
Beam Therapeutics Technical Analysis
Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Beam Therapeutics Stock
Is Beam Therapeutics Stock a Buy?
-
Beam Therapeutics share price is 26.39 while BEAM 8-day simple moving average is 25.85, which is a Buy signal.
-
The stock price of BEAM is 26.39 while Beam Therapeutics 20-day SMA is 27.22, which makes it a Sell.
-
Beam Therapeutics 50-day simple moving average is 26.35 while BEAM share price is 26.39, making it a Buy technically.
-
BEAM stock price is 26.39 and Beam Therapeutics 200-day simple moving average is 25.50, creating a Buy signal.
BEAM Technical Analysis vs Fundamental Analysis
Sell
47
Beam Therapeutics (BEAM)
is a Sell
Is Beam Therapeutics a Buy or a Sell?
-
Beam Therapeutics stock is rated a SellThe current Beam Therapeutics [BEAM] share price is $26.39. The Score for BEAM is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Beam Therapeutics Stock Info
Market Cap:
2.2B
Price in USD:
26.39
Share Volume:
1.6M
Beam Therapeutics 52-Week Range
52-Week High:
49.50
52-Week Low:
20.84
Sell
47
Beam Therapeutics (BEAM)
is a Sell
Beam Therapeutics Share Price Forecast
-
What is the Beam Therapeutics stock price today?The Beam Therapeutics stock price is 26.39 USD today.
-
Will BEAM stock go up or go down?Beam Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Beam Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Beam Therapeutics is overvalued.
Is Beam Therapeutics Stock a Buy?
-
Beam Therapeutics share price is 26.39 while BEAM 8-day exponential moving average is 26.45, which is a Sell signal.
-
The stock price of BEAM is 26.39 while Beam Therapeutics 20-day EMA is 26.72, which makes it a Sell.
-
Beam Therapeutics 50-day exponential moving average is 26.38 while BEAM share price is 26.39, making it a Buy technically.
-
BEAM stock price is 26.39 and Beam Therapeutics 200-day simple moving average is 26.33, creating a Buy signal.
Fundamental Analysis of Beam Therapeutics
Is Beam Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and an increase next year of $0.19 per share.
Technical Analysis of Beam Therapeutics
Should I short Beam Therapeutics stock?
-
BEAM Moving Average Covergence Divergence (MACD) indicator is -0.13, suggesting Beam Therapeutics is a Sell
-
Beam Therapeutics Relative Strength Index (RSI) is 48.59, which suggest Beam Therapeutics is oversold
-
The Bollinger Bands (25) for Beam Therapeutics is (25.71 - 28.69), which suggest Beam Therapeutics is a Buy
-
The Bollinger Bands (100) for Beam Therapeutics is (23.5 - 27.4), which suggest Beam Therapeutics is a Buy
* Beam Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.